Justin Renz

Justin A. Renz is currently Chief Financial Officer & Treasurer at Zevra Therapeutics, Inc. since 2026.
Formerly, Mr. Renz was Chief Operating Officer at Ardelyx, Inc. from 2025 to 2025; President & Chief Financial Officer at Correvio Pharma Corp.
from 2019 to 2020; Chief Financial Officer, Treasurer & Executive Vice President at Karyopharm Therapeutics, Inc. from 2015 to 2017; Chief Financial Officer, Treasurer, Senior Vice President & General Counsel at CombinatoRx, Inc. from 2010 to 2014; Chief Financial Officer & Executive Vice President at Zalicus Pharmaceuticals Ltd. from 2006 to 2014; Director-Accounting & Financial Operations at EMD Serono, Inc. in 2006; Senior Director-Global Accounting & Finance at Coley Pharmaceutical Group, Inc. in 2005; and held principal roles at EMD Millipore Corp., ArQule, Inc., and Arthur Andersen LLP.
Education includes undergraduate studies at College of the Holy Cross (Massachusetts), an MBA from Suffolk University, and graduate studies at Northeastern University.